000 | 01753 a2200481 4500 | ||
---|---|---|---|
005 | 20250513222930.0 | ||
264 | 0 | _c20001121 | |
008 | 200011s 0 0 eng d | ||
022 | _a0022-3565 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKamosinska, B | |
245 | 0 | 0 |
_aRole of inducible nitric-oxide synthase in regulation of whole-cell current in lung epithelial cells. _h[electronic resource] |
260 |
_bThe Journal of pharmacology and experimental therapeutics _cNov 2000 |
||
300 |
_a500-5 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aCyclic GMP _xmetabolism |
650 | 0 | 4 |
_aCytokines _xpharmacology |
650 | 0 | 4 | _aEnzyme Activation |
650 | 0 | 4 |
_aGlutathione _xanalogs & derivatives |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInterferon-gamma _xpharmacology |
650 | 0 | 4 |
_aInterleukin-1 _xpharmacology |
650 | 0 | 4 |
_aIon Channels _xmetabolism |
650 | 0 | 4 |
_aLung _xdrug effects |
650 | 0 | 4 |
_aMembrane Potentials _xdrug effects |
650 | 0 | 4 |
_aNitrates _xmetabolism |
650 | 0 | 4 |
_aNitric Oxide _xmetabolism |
650 | 0 | 4 |
_aNitric Oxide Donors _xpharmacology |
650 | 0 | 4 |
_aNitric Oxide Synthase _xantagonists & inhibitors |
650 | 0 | 4 | _aNitric Oxide Synthase Type II |
650 | 0 | 4 | _aNitric Oxide Synthase Type III |
650 | 0 | 4 |
_aNitroso Compounds _xpharmacology |
650 | 0 | 4 | _aPatch-Clamp Techniques |
650 | 0 | 4 | _aRecombinant Proteins |
650 | 0 | 4 | _aS-Nitrosoglutathione |
650 | 0 | 4 | _aTumor Cells, Cultured |
650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xpharmacology |
700 | 1 | _aRadomski, A | |
700 | 1 | _aMan, S F | |
700 | 1 | _aRadomski, M W | |
700 | 1 | _aDuszyk, M | |
773 | 0 |
_tThe Journal of pharmacology and experimental therapeutics _gvol. 295 _gno. 2 _gp. 500-5 |
|
999 |
_c10991050 _d10991050 |